KALEE GOLDEN: Open Payments
NPI 1265799159 · SYLVA, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,038 in 125 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $1,221 · 2025 $2,038
Food & beverage: $2,038
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $417 |
| Novo Nordisk Inc | 18 | $279 |
| PFIZER INC. | 12 | $231 |
| AstraZeneca Pharmaceuticals LP | 10 | $206 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $164 |
| GlaxoSmithKline, LLC. | 7 | $150 |
| Lilly USA, LLC | 6 | $120 |
| Exact Sciences Corporation | 5 | $73 |
| Corcept Therapeutics | 4 | $58 |
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
Products named: Ozempic, VRAYLAR, UBRELVY, Kerendia, NURTEC ODT, TRELEGY ELLIPTA, AIRSUPRA, Cologuard Collection Kit.
Industry payments across NC — which companies pay providers there.
